G olf protein levels in rat striatum are increased by chronic antidepressant administration and decreased by olfactory bulbectomy

Abstract

There are many studies of the mechanisms of antidepressants; however, most of these studies were conducted on the hippocampus or frontal cortex. In the present study, we hypothesized that the nucleus accumbens and caudate/putamen might be major targets for antidepressant effects. Thus, we focused on G olf protein, a stimulant α-subunit of G protein that is coupled with the dopamine D1 receptor and specifically expressed in the striatum (nucleus accumbens, caudate/putamen and olfactory tubercle) in the rat brain. We examined the effects of chronic administration of imipramine, fluvoxamine, maprotiline and, as a negative control, cocaine on the level of G olf protein in the rat striatum. We also examined the effect of olfactory bulbectomy. Chronic imipramine treatment (10 mg/kg for 2 or 4 weeks) significantly increased the level of G olf in the striatum (by 17% or 18%, respectively), although this increase was not apparent after only 1 week of treatment. The time course of these changes corresponded well to that of the clinical efficacy of imipramine. Chronic fluvoxamine and maprotiline treatment (20 mg/kg for 2 weeks) also significantly increased the level of G olf (by 9% and 25%, respectively), but cocaine did not alter it significantly. Bulbectomy decreased the G olf protein level by 9%. The increases in G olf protein after chronic administration of these three different classes of antidepressants and the decrease after bulbectomy suggest that G olf protein may play an important role in the antidepressant effect.